HIP & KNEE

HIP & KNEE

100 – What is the most optimal VTE prophylaxis following TKA/THA? https://icmphilly.com/?page_id=11296

102 – Is there a difference in VTE risk profile for patients undergoing total hip arthroplasty or total knee arthroplasty? https://icmphilly.com/?page_id=11282

103 – Should mechanical compressive devices be used routinely in patients undergoing total hip arthroplasty or total knee arthroplasty? https://icmphilly.com/?page_id=10433

104 – Should pneumatic compression devices (PCD) routinely be co-administered to patients receiving aspirin for VTE prophylaxis? https://icmphilly.com/?page_id=11287

105 – Considering the trend to ambulatory hip and knee arthroplasty, is there a role for the use of pneumatic compression devices? https://icmphilly.com/?page_id=10429

106 – What is the chemoprophylactic agent of choice for patients undergoing simultaneous bilateral total hip arthroplasty (SBTHA)? https://icmphilly.com/?page_id=10346

107 – What is the chemoprophylactic agent of choice for patients undergoing simultaneous bilateral total knee arthroplasty (SBTKA)? https://icmphilly.com/?page_id=10340

108 – Do patients undergoing UKA, including patellofemoral joint arthroplasty, have a different VTE risk profile compared to TKA? https://icmphilly.com/?page_id=10723

109 – Does the “enhanced recovery” concept, which includes early ambulation, reduce the risk of VTE in patients undergoing primary total hip or knee arthroplasty? https://icmphilly.com/?page_id=11278

110 – Does the use of Continuous Passive Machine (CPM) reduce the risk of VTE following knee surgery? https://icmphilly.com/?page_id=11274

111 – Should the use of lower extremity tourniquet be avoided in patients at a high risk of VTE? https://icmphilly.com/?page_id=10316

112 – Is VTE after elective total joint arthroplasty a “never event”? https://icmphilly.com/?page_id=11267

113 – What is the optimal choice for VTE prophylaxis following two-stage or resection arthroplasty for treatment of knee and hip periprosthetic joint infection? https://icmphilly.com/?page_id=11263

114 – Should the method for VTE prophylaxis be altered in patients undergoing revision for infection? https://icmphilly.com/?page_id=11304

115 – Do patients undergoing elective pelvic and/or femoral osteotomy require routine VTE prophylaxis? https://icmphilly.com/?page_id=10441

116 What are the indications for Doppler ultrasound of the lower extremity to confirm or rule out DVT? https://icmphilly.com/?page_id=10636

117 – Should the presence of a distal DVT in an extremity mandate repeat imaging of proximal veins? https://icmphilly.com/?page_id=10225

118 -What is the incidence of readmission and re-operation for hematomas secondary to administration of chemoprophylaxis for VTE in patients undergoing total joint arthroplasty? https://icmphilly.com/?page_id=11300

119 – Which VTE prophylactic agent used in patients undergoing TKA/THA has the highest bleeding rate? https://icmphilly.com/?page_id=10463

120 – Does the type of VTE prophylaxis influence the risk of subsequent periprosthetic joint infection in patients undergoing joint arthroplasty? https://icmphilly.com/?page_id=11239

121 – Does the type of VTE prophylaxis influence the risk of subsequent surgical site infection (SSI) in patients undergoing orthopaedic procedures? https://icmphilly.com/?page_id=11233

%d bloggers like this: